LabConnect & OmniScience Launch First Agentic AI for Real-Time Clinical Labs
Together we’re unlocking the true potential of scientific trial lab knowledge, bringing sooner insights, smarter selections, and higher outcomes.
LabConnect, a number one world supplier of central laboratory providers immediately introduced plans to type a strategic collaboration with OmniScience, the AI firm behind Vivo, the primary agentic AI management tower for scientific trials. Together, they’ll ship the trade’s first AI-driven answer enabling sponsors to achieve clever, real-time insights from scientific trial lab knowledge.
Faster Decisions and Smarter Oversight with LabConnect + Vivo
Clinical trial lab knowledge is commonly siloed, advanced, and delayed. This causes gradual decision-making and introduces danger. By combining LabConnect’s experience in central lab testing and knowledge administration with OmniScience’s Vivo platform, trial sponsors can now unify fragmented lab datasets, automate oversight, and floor danger alerts that speed up trial timelines and enhance outcomes.
About Vivo: Real-Time Intelligence for Clinical Trials, Purpose-Built for Lab Data
Vivo is an AI-native scientific trial intelligence platform that transforms how groups work together with knowledge throughout the scientific improvement lifecycle. Designed to unify disparate sources and ship real-time insights, Vivo features as a management tower equipping scientific, operational, security, and knowledge science groups with the readability to behave sooner and extra confidently. Vivo-Lab, a specialised implementation of Vivo, brings this identical intelligence to laboratory knowledge. Vivo-Lab streamlines lab workflows by surfacing essential traits, anomalies, and site-level discrepancies as they occur, serving to groups transfer from reactive to proactive oversight in one of the vital advanced and variable knowledge streams in scientific analysis.
Transforming Lab Data into Real-Time Action
“Our mission at OmniScience is to assist trial groups see and act sooner,” mentioned Angela Holmes, CEO and Co-Founder of OmniScience. “Partnering with LabConnect extends that imaginative and prescient by remodeling lab knowledge into actual time actionable intelligence that sponsors can belief.”
Wes Wheeler, CEO of LabConnect, added: “At LabConnect, we’re dedicated to serving to sponsors unlock the total potential of their lab knowledge. By integrating OmniScience’s transformative AI, we’re shifting lab outcomes from static studies into dynamic, actionable intelligence. Together, we’re giving scientific operations groups the pace, agility, and precision they should make smarter selections, enhance trial effectivity, and convey therapies to sufferers sooner.”
The partnership underscores each organizations’ dedication to innovation in scientific improvement, bringing collectively LabConnect’s technology-driven laboratory operations and OmniScience’s AI-native strategy to trial intelligence.
The put up LabConnect & OmniScience Launch First Agentic AI for Real-Time Clinical Labs first appeared on AI-Tech Park.
